NCT03497377View on ClinicalTrials.gov

Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 16, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Metastatic Prostate Cancer
Interventions
DRUG

18F-DCFPyL Injection

DRUG

18F-NaF

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT03497377 - Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer. | Biotech Hunter | Biotech Hunter